Maureen Bocian
University of California, Irvine
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Maureen Bocian.
Cell | 1994
Rita Shiang; Leslie M. Thompson; Ya-Zhen Zhu; Deanna Church; Thomas J. Fielder; Maureen Bocian; Sara T. Winokur; John J. Wasmuth
Achondroplasia (ACH) is the most common genetic form of dwarfism. This disorder is inherited as an autosomal dominant trait, although the majority of cases are sporadic. A gene for ACH was recently localized to 4p16.3 by linkage analyses. The ACH candidate region includes the gene encoding fibroblast growth factor receptor 3 (FGFR3), which was originally considered as a candidate for the Huntingtons disease gene. DNA studies revealed point mutations in the FGFR3 gene in ACH heterozygotes and homozygotes. The mutation on 15 of the 16 ACH-affected chromosomes was the same, a G-->A transition, at nucleotide 1138 of the cDNA. The mutation on the only ACH-affected chromosome 4 without the G-->A transition at nucleotide 1138 had a G-->C transversion at this same position. Both mutations result in the substitution of an arginine residue for a glycine at position 380 of the mature protein, which is in the transmembrane domain of FGFR3.
American Journal of Medical Genetics Part A | 2006
Janet E. Lainhart; Erin D. Bigler; Maureen Bocian; Hilary Coon; Elena Dinh; Geraldine Dawson; Curtis K. Deutsch; Michelle Dunn; Annette Estes; Helen Tager-Flusberg; Susan E. Folstein; Susan Hepburn; Susan L. Hyman; William M. McMahon; Nancy J. Minshew; Jeff Munson; Kathy Osann; Sally Ozonoff; Patricia M. Rodier; Sally J. Rogers; Marian Sigman; M. Anne Spence; Christopher J. Stodgell; Fred R. Volkmar
Data from 10 sites of the NICHD/NIDCD Collaborative Programs of Excellence in Autism were combined to study the distribution of head circumference and relationship to demographic and clinical variables. Three hundred thirty‐eight probands with autism‐spectrum disorder (ASD) including 208 probands with autism were studied along with 147 parents, 149 siblings, and typically developing controls. ASDs were diagnosed, and head circumference and clinical variables measured in a standardized manner across all sites. All subjects with autism met ADI‐R, ADOS‐G, DSM‐IV, and ICD‐10 criteria. The results show the distribution of standardized head circumference in autism is normal in shape, and the mean, variance, and rate of macrocephaly but not microcephaly are increased. Head circumference tends to be large relative to height in autism. No site, gender, age, SES, verbal, or non‐verbal IQ effects were present in the autism sample. In addition to autism itself, standardized height and average parental head circumference were the most important factors predicting head circumference in individuals with autism. Mean standardized head circumference and rates of macrocephaly were similar in probands with autism and their parents. Increased head circumference was associated with a higher (more severe) ADI‐R social algorithm score. Macrocephaly is associated with delayed onset of language. Although mean head circumference and rates of macrocephaly are increased in autism, a high degree of variability is present, underscoring the complex clinical heterogeneity of the disorder. The wide distribution of head circumference in autism has major implications for genetic, neuroimaging, and other neurobiological research.
Annals of Neurology | 2003
Pauline A. Filipek; Jenifer Juranek; Moyra Smith; Lee Zellmer Mays; Erica R. Ramos; Maureen Bocian; Diane Masser-Frye; Tracy M. Laulhere; Charlotte Modahl; M. Anne Spence; J. Jay Gargus
Two autistic children with a chromosome 15q11‐q13 inverted duplication are presented. Both had uneventful perinatal courses, normal electroencephalogram and magnetic resonance imaging scans, moderate motor delay, lethargy, severe hypotonia, and modest lactic acidosis. Both had muscle mitochondrial enzyme assays that showed a pronounced mitochondrial hyperproliferation and a partial respiratory chain block most parsimoniously placed at the level of complex III, suggesting candidate gene loci for autism within the critical region may affect pathways influencing mitochondrial function. Ann Neurol 2003;53:801–804
American Journal of Medical Genetics | 1996
Geert R. Mortier; Ralph S. Lachman; Maureen Bocian; David L. Rimoin
To further delineate and classify those forms of short trunk dwarfism characterized by multiple vertebral segmentation defects, we analyzed 26 new patients and reviewed 115 described in the literature. Three distinct entities were recognized based on radiographic and clinical findings. Jarcho-Levin syndrome is the lethal autosomal recessive form, characterized by a symmetric crab-like chest. Spondylocostal dysostosis is the benign autosomal dominant condition. Spondylothoracic dysostosis shows considerable clinical and radiographic overlap with spondylocostal dysostosis. Malformations observed in association with multiple vertebral segmentation defects are more common in the sporadic patients. Analysis of the 26 new individuals revealed that the body segment in which these nonvertebral malformations occur corresponds to the site of the vertebral segmentation defects.
Human Mutation | 2010
Jennifer J. Johnston; Julie C. Sapp; Joyce T. Turner; David J. Amor; Salim Aftimos; Kyrieckos A. Aleck; Maureen Bocian; Joann Bodurtha; Gerald F. Cox; Cynthia J. Curry; Ruth Day; Dian Donnai; Michael Field; Ikuma Fujiwara; Michael T. Gabbett; Moran Gal; John M. Graham; Peter Hedera; Raoul C. M. Hennekam; Joseph H. Hersh; Robert J. Hopkin; Hülya Kayserili; Alexa Kidd; Virginia E. Kimonis; Angela E. Lin; Sally Ann Lynch; Melissa Maisenbacher; Sahar Mansour; Julie McGaughran; Lakshmi Mehta
A range of phenotypes including Greig cephalopolysyndactyly and Pallister‐Hall syndromes (GCPS, PHS) are caused by pathogenic mutation of the GLI3 gene. To characterize the clinical variability of GLI3 mutations, we present a subset of a cohort of 174 probands referred for GLI3 analysis. Eighty‐one probands with typical GCPS or PHS were previously reported, and we report the remaining 93 probands here. This includes 19 probands (12 mutations) who fulfilled clinical criteria for GCPS or PHS, 48 probands (16 mutations) with features of GCPS or PHS but who did not meet the clinical criteria (sub‐GCPS and sub‐PHS), 21 probands (6 mutations) with features of PHS or GCPS and oral‐facial‐digital syndrome, and 5 probands (1 mutation) with nonsyndromic polydactyly. These data support previously identified genotype–phenotype correlations and demonstrate a more variable degree of severity than previously recognized. The finding of GLI3 mutations in patients with features of oral–facial–digital syndrome supports the observation that GLI3 interacts with cilia. We conclude that the phenotypic spectrum of GLI3 mutations is broader than that encompassed by the clinical diagnostic criteria, but the genotype–phenotype correlation persists. Individuals with features of either GCPS or PHS should be screened for mutations in GLI3 even if they do not fulfill clinical criteria. Hum Mutat 31:1142–1154, 2010.
BMC Medical Genetics | 2004
Subhadra Ramanathan; Abigail Woodroffe; Pamela Flodman; Lee Zellmer Mays; Mona Hanouni; Charlotte Modahl; Robin Steinberg-Epstein; Maureen Bocian; M. Anne Spence; Moyra Smith
BackgroundAutism is a pervasive developmental disorder characterized by a triad of deficits: qualitative impairments in social interactions, communication deficits, and repetitive and stereotyped patterns of behavior. Although autism is etiologically heterogeneous, family and twin studies have established a definite genetic basis. The inheritance of idiopathic autism is presumed to be complex, with many genes involved; environmental factors are also possibly contributory. The analysis of chromosome abnormalities associated with autism contributes greatly to the identification of autism candidate genes.Case presentationWe describe a child with autistic disorder and an interstitial deletion on chromosome 4q. This child first presented at 12 months of age with developmental delay and minor dysmorphic features. At 4 years of age a diagnosis of Pervasive Developmental Disorder was made. At 11 years of age he met diagnostic criteria for autism. Cytogenetic studies revealed a chromosome 4q deletion. The karyotype was 46, XY del 4 (q31.3-q33). Here we report the clinical phenotype of the child and the molecular characterization of the deletion using molecular cytogenetic techniques and analysis of polymorphic markers. These studies revealed a 19 megabase deletion spanning 4q32 to 4q34. Analysis of existing polymorphic markers and new markers developed in this study revealed that the deletion arose on a paternally derived chromosome. To date 33 genes of known or inferred function are deleted as a consequence of the deletion. Among these are the AMPA 2 gene that encodes the glutamate receptor GluR2 sub-unit, GLRA3 and GLRB genes that encode glycine receptor subunits and neuropeptide Y receptor genes NPY1R and NPY5R.ConclusionsThe deletion in this autistic subject serves to highlight specific autism candidate genes. He is hemizygous for AMPA 2, GLRA3, GLRB, NPY1R and NPY5R. GluR2 is the major determinant of AMPA receptor structure. Glutamate receptors maintain structural and functional plasticity of synapses. Neuropeptide Y and its receptors NPY1R and NPY5R play a role in hippocampal learning and memory. Glycine receptors are expressed in very early cortical development. Molecular cytogenetic studies and DNA sequence analysis in other patients with autism will be necessary to confirm that these genes are involved in autism.
Cytogenetic and Genome Research | 2001
Moyra Smith; Julienne Escamilla; Pauline A. Filipek; Maureen Bocian; Charlotte Modahl; Pamela Flodman; M. A. Spence
We recently studied a patient who meets criteria for autistic disorder and has a 2q37 deletion. Molecular cytogenetic studies were carried out using DNA isolated from 22 different 2q37 mapped BACs to more precisely define the extent of the chromosome deletion. We also analyzed 2q37 mapped polymorphic markers. In addition DNA sequences of BACs in the deletion region were scanned to identify microsatellite repeats. We describe four new polymorphic microsatellite repeat markers in the 2q37.3 region. These markers enabled us to determine the parental origin of the deletion in our patient. DNA from 8–13 unrelated individuals was used to determine heterozygosity estimates for these markers. We review four genes deleted in our patient – genes whose known functions and sites of expression in the brain and/or bone make them candidates for involvement in autism and/or the osteodystrophy observed in patients with 2q37.3 deletions.
American Journal of Medical Genetics | 2000
Moyra Smith; Pauline A. Filipek; Charles Wu; Maureen Bocian; Simin Hakim; Charlotte Modahl; M. Anne Spence
We have identified a one megabase deletion in the 15q22-15q23 region in a patient with autism, developmental delay, and mild dysmorphism. Genes that map within the deletion region and genes that are interrupted or rearranged at the deletion breakpoints are candidate genes for autism. Fluroescence in situ hybridization studies in this patient revealed that part or all of the PML gene is absent from one chromosome 15 and a BAC clone containing the D15S124 gene locus hybridizes to only one chromosome 15. BAC clones containing the PTPN9, and SLP-1[hUNC24] genes showed markedly reduced hybridization in the 15q22-q23 region on one chromosome 15 in the patient. These BACs also hybridize to the 15q11-q13 region in close proximity to SNRPN and HERC2, and in this region there is equal intensity of signal on the normal and on the deleted chromosome. There are previous reports of deletions and duplications of the 15q11-q13 region in patients with autism. Our patient represents the first report of a 15q22-q23 deletion. Hybridization of the PTPN9 and Slp-1 Bac clones to the 15q11-q13 and the 15q22-q23 regions of chromosome 15 may be due to the presence of PTPN9 or SLP-1 gene sequences or to the presence of other gene sequences or to non-coding homologous DNA sequences. The PTPN9 gene encodes a non-receptor protein tyrosine phosphatase. The Slp-1 [hUNC24] gene is expressed mainly in the brain. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 96:765-770, 2000.
The Journal of Pediatrics | 1984
Ira T. Lott; Maureen Bocian; Henry W. Pribram; Marc Leitner
Collins syndrome and may have resulted f rom defective migra t ion of neural crest cells f rom the first and second branchia l arches?. 2 Including this case, there are now 16 women retrospectively identified as having taken isotretinoin dur ing pregnancy. 3,4 Outcomes from these pregnancies include six spontaneous abortions, one normal infant , and nine infants with malformat ions . Of 18 women identified dur ing pregnancy who did not in ter rupt the pregnancy, the outcomes have included 13 spontaneous abort ions, four normal children, and one abnormal child. Therefore, in 15 pregnancies t ha t have come to term, five chi ldren were normal at b i r th and 10 were abnormal . O f the 10 abno rma l children, seven had microt ia with or wi thout agenesis of the external ear canal, nine had cent ra l nervous system abnormal i t ies , and four had congeni tal hear t defects. A l though the guidelines for using isotret inoin are established, each physician must decide whether the benefit of prescribing any retinoid outweighs the chance tha t the pa t ient will conceive while taking the d rug? Despite cur ren t warnings, with increased use of isotret inoin in women of chi ldbear ing age more f requent inadver ten t exposures have occurred. Unt i l the relat ionship between the dose and dura t ion of exposure with the likelihood and severity of a mal format ion is be t ter understood, the desirabil i ty of cont inuing the pregnancy af ter an exposure should be discussed. Physicians should document tha t sexually active female pat ients are not p regnant when the drug is begun, are using effective b i r th control methods, and are provided with wr i t ten informat ion about the teratogenic effects of this drug.
Cytogenetic and Genome Research | 2002
Moyra Smith; A. Woodroffe; R. Smith; S. Holguin; J. Martinez; Pauline A. Filipek; Charlotte Modahl; B. Moore; Maureen Bocian; Lee Zellmer Mays; Tracy M. Laulhere; Pamela Flodman; M.A. Spence
In a sporadic case of autism and language deficit due to auditory processing defects, molecular genetic studies revealed that a chromosomal deletion occurred in the 13q12→q13 region. No chromosome abnormalities were detected in the parents. We determined that the deletion occurred on the paternally derived chromosome 13. There are two previous reports of chromosome 13 abnormalities in patients with autism. The deletion in the subject described in this paper maps between the two chromosome 13 linkage peaks described by Bradford et al. (2001) in studies of subjects with autism and language deficits. The 9-Mb region deleted in the patient described here contains at least four genes that are expressed in brain and that play a role in brain development. They are NBEA, MAB21L1, DCAMKL1 and MADH9. These genes therefore represent candidate genes for autism and specific language deficits.